Navigation Links
NYSCF awards fellowships to 8 innovative stem cell scientists
Date:6/1/2010

outstanding. I am very proud of the fellows that have been chosen by the committee throughout the years. By supporting the next generation of stem cell researchers, I see the NYSCF Fellowship Program as a flagship for the Foundation's transformative efforts on behalf of stem cell research," said Dr. Ruth Lehmann, Co-Chair of the Fellowship Review Committee and Director of the Helen and Martin Kimmel Center for Stem Cell Biology at NYU School of Medicine.

The New York Stem Cell Foundation Fellows are applying stem cell technologies towards the development of therapeutics for a variety of medical conditions.

The 2010 Fellows:

  • Elisa Cimetta, PhD, working with Dr. Gordana Vunjak-Novakovic at Columbia University, is using advanced technologies to study and direct stem cell differentiation.

  • Natalie Kim, PhD, working with Dr. Lee Rubin at Harvard University, is finding improved ways to generate brain cells from adult cells for the treatment of ALS.

  • Ian Martin, PhD, working with Dr. Ted Dawson at Johns Hopkins University, is generating and characterizing neurons from Parkinson's disease patients.

  • Jae-won Shim, PhD, working with Dr. Lorenz Studer of Memorial Sloan-Kettering Cancer Center, is using stem cells from patients to model Parkinson's disease.

  • Chutima "Noi" Talchai, PhD, working with Dr. Domenico Accili at Columbia University, is turning intestinal cells into functional insulin-producing cells, which is crucial to the development of Type I diabetes therapies.

  • Maya Tevlin, PhD, working with Dr. Shai Shaham at The Rockefeller University, is modeling cell conversion during development to identify strategies for new regenerative therapeutics.

  • George Kai Wang, PhD, working with Dr. Robert Kass at Columbia University, is developing ways to model and treat life-threatening heart conditions and sudden cardiac death using stem cells.

  • Oren Ziv, PhD, working with Dr. Yuval
    '/>"/>

Contact: Nadine Woloshin
nwoloshin@rubenstein.com
212-843-8041
New York Stem Cell Foundation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. NYSCF Fellow lead author on study that creates blood vessel cells from stem cells
2. NYSCF fellow lead author on study that derives floor plate tissue from embryonic stem cells
3. NYSCF receives $27 million grant from Robertson Foundation to promote stem cell research
4. The American Society of Plant Biologists announces 2007 awards
5. Singapore National Science and Technology Awards
6. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
7. NIH awards nearly $23M to University of Chicago for translational research
8. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
9. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
10. NIH awards UC $9 million grant to improve patient point-of-care technologies
11. NIST announces 56 new awards for innovative technology research and development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/3/2014)... Research and Markets has announced the addition of a ... to their offering. This report describes ... started to play an important role in the practice of ... bone marrow transplants. Role of cells in drug discovery is ... of medical practice. Stem cells are discussed in ...
(Date:11/3/2014)... Australia report that low birth weight and preterm birth ... replacements in adulthood. Findings published in the American College ... , indicate that low birth weight and pre-term babies ... to OA as adults. , According to the ... are diagnosed with clinical OA. Symptoms of OA range ...
(Date:11/2/2014)... was fascinating to put a flashlight up to our ... Washington University in St. Louis engineers are using a ... to improve imaging of cancerous tissues and to develop ... K. Beare Distinguished Professor of Biomedical Engineering at the ... novel time-reversal technology that allows researchers to better focus ...
Breaking Biology News(10 mins):Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3Preterm, low birth-weight babies may need new hips in adulthood 2Improving imaging of cancerous tissues by reversing time 2
... Louis, MO, May 11, 2009 As the childhood obesity ... early parent and child behaviors contribute to the problem. A ... in the May/June 2009 issue of the Journal of ... signs of satiety in their infants tend to overfeed them, ...
... world,s second largest fish hide out for half ... on May 7th in Current Biology , a ... the iconic species and highlights just how little we ... the researchers said. "While commonly sighted in surface ...
... team of researchers from the United States, the Netherlands ... that are associated with altered kidney disease risk. One ... protein, the most common protein in the urine of ... for almost 60 years, its functions are not well ...
Cached Biology News:Does mom know when enough is enough? 2Disappearing act of world's second largest fish explained 2Study finds novel genetic risk factors for kidney disease 2
(Date:11/21/2014)... 20, 2014 The report, ... Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, ... Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to ... drivers, threats, opportunities, and challenges. , Browse ... spread through 185 pages and in-depth TOC ...
(Date:11/21/2014)... 21, 2014 2014 Deep Research ... is a professional and in-depth research report on ... information, like its definition, classification, application, and ... This report covers the international market analysis, including ... as the US, Europe, Asia, China, Japan etc. ...
(Date:11/21/2014)... and SAN DIEGO , Nov. ... today announced that President and CEO Marc Hedrick , M.D. ... DATE:   Thursday, December 4, 2014 TIME:    ... here or paste this URL into your browser,s ... that investors pre-register to save time and receive event updates. ...
(Date:11/18/2014)... New Orleans, LA (PRWEB) November 17, 2014 ... developer of build-to-order, open architecture blade-based and rackmount ... new NVIDIA® Tesla® K80 dual-GPU accelerator throughout its ... Utilizing a pair of the company‚Äôs latest proprietary ... up to eight discrete NVIDIA Tesla K80 dual-GPU ...
Breaking Biology Technology:Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4Cirrascale® Expands Multi-GPU Peering Solutions with Support for New NVIDIA Tesla K80 Dual-GPU Accelerators 2Cirrascale® Expands Multi-GPU Peering Solutions with Support for New NVIDIA Tesla K80 Dual-GPU Accelerators 3
... Inc. (Nasdaq: EXEL ) today announced that ... Inc. (Hudson, NY) pursuant to which Exelixis,sold Taconic ... GmbH,for approximately $20 million, subject to certain post-closing ... and commercialization of,genetically engineered mouse models and engineered ...
... LAKE, N.J., Nov. 20 Barr,Pharmaceuticals, Inc. (NYSE: ... Barr,Laboratories, Inc., has initiated a challenge of the ... 10mg, 15mg & 20mg. Focalin XR is manufactured ... Holdings Inc. Barr filed its Abbreviated New ...
... FRANKLIN, Mass., Nov. 20 Echo Therapeutics,Inc. (OTC ... quarter ended September 30, 2007. For the quarter ended ... share, compared to $1,390,000 or,$.49 per share, for the ... 30, 2007, net loss was $10,278,000, or $1.05 per ...
Cached Biology Technology:Exelixis Sells 80% Stake in Artemis to Taconic 2Exelixis Sells 80% Stake in Artemis to Taconic 3Exelixis Sells 80% Stake in Artemis to Taconic 4Barr Confirms Patent Challenge of Focalin(R) XR 2Barr Confirms Patent Challenge of Focalin(R) XR 3Echo Therapeutics Reports Third Quarter 2007 Results 2Echo Therapeutics Reports Third Quarter 2007 Results 3Echo Therapeutics Reports Third Quarter 2007 Results 4Echo Therapeutics Reports Third Quarter 2007 Results 5Echo Therapeutics Reports Third Quarter 2007 Results 6